Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 97,231 | 97,529 | 117,130 | 103,747 | 104,031 |
| Gross Profit | 97,231 | 97,529 | 117,130 | 103,747 | 104,031 |
| Operating Expenses | 41,576 | 39,683 | 60,538 | 38,576 | 38,933 |
| Operating Income | 55,655 | 57,846 | 56,592 | 65,171 | 65,098 |
| Interest Expense | 2,207 | 2,341 | 7,951 | 7,841 | 7,732 |
| Other Income | 337 | 960 | -2,386 | 2,342 | -2,994 |
| Pre-tax Income | 53,785 | 56,465 | 46,255 | 59,672 | 54,372 |
| Income Tax | 16,705 | 17,664 | 4,881 | 3,827 | -336,931 |
| Net Income Continuous | 37,080 | 38,801 | 41,374 | 55,845 | 391,303 |
| Net Income | $37,080 | $38,801 | $41,374 | $55,845 | $391,303 |
| EPS Basic Total Ops | 0.24 | 0.25 | 0.25 | 0.34 | 2.42 |
| EPS Basic Continuous Ops | 0.24 | 0.25 | 0.25 | 0.34 | 2.42 |
| EPS Diluted Total Ops | 0.21 | 0.21 | 0.23 | 0.34 | 2.39 |
| EPS Diluted Continuous Ops | 0.20 | 0.20 | 0.24 | 0.34 | 2.39 |
| EBITDA(a) | $56,015 | $58,201 | $56,951 | $65,529 | $65,494 |